Cell line · CVCL_5160
NCI-H3122
Cancer cell line, Homo sapiens. Lung adenocarcinoma. 34 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H3122. Cell lines, record CVCL_5160. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_5160
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H3122
- Accession
- CVCL_5160
- RRID
- RRID:CVCL_5160
- Synonyms
- H3122, H-3122, NCIH3122
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 54Y
- Category
- Cancer cell line
- Diseases
- Lung adenocarcinoma (NCIt C3512)
- Derived from
- Pleural effusion (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers34
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Systematic Targeting of Protein Complexes with Molecular COUPLrs. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integration and validation of complementary ex vivo assays for functional precision oncology. | NPJ Precis Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A comprehensive functional atlas of ALK kinase domain variants reveals resistance landscape to ALK inhibitors. | Genome Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis. | Cancer Metab | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma. | Mol Cell | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| AXL and SHC1 confer crizotinib resistance in patient-derived xenograft model of ALK-driven lung cancer. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 37994369 | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 34
See all 34 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE NCI-H3122-Cas9 | CVCL_F5QB | Cell lines | |
| Derived from it | EDITGENE NCI-H3122-CopGFP | CVCL_F6AC | Cell lines | |
| Derived from it | EDITGENE NCI-H3122-FLUC | CVCL_F5T3 | Cell lines | |
| Derived from it | NCI-H3122-CHR-A1 | CVCL_4Y37 | Cell lines | |
| Derived from it | NCI-H3122-CR1 | CVCL_AY53 | Cell lines |
Cell banks3
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 300484 | CLS | |
| EDITGENE | EDC00236 | EDITGENE | |
| NCI-DCTD | NCI-H3122 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5160
GET https://conductscience.org/api/cell-lines/v1/CVCL_5160/papers?page=2